193 related articles for article (PubMed ID: 17765543)
1. Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores.
Keith JM; Barbier AJ; Wilson SJ; Miller K; Boggs JD; Fraser IC; Mazur C; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 Oct; 17(19):5325-9. PubMed ID: 17765543
[TBL] [Abstract][Full Text] [Related]
2. Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophore.
Keith JM; Gomez LA; Letavic MA; Ly KS; Jablonowski JA; Seierstad M; Barbier AJ; Wilson SJ; Boggs JD; Fraser IC; Mazur C; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 Feb; 17(3):702-6. PubMed ID: 17107798
[TBL] [Abstract][Full Text] [Related]
3. Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors.
Keith JM; Gomez LA; Barbier AJ; Wilson SJ; Boggs JD; Lord B; Mazur C; Aluisio L; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 Aug; 17(15):4374-7. PubMed ID: 17583504
[TBL] [Abstract][Full Text] [Related]
4. Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.
Letavic MA; Keith JM; Jablonowski JA; Stocking EM; Gomez LA; Ly KS; Miller JM; Barbier AJ; Bonaventure P; Boggs JD; Wilson SJ; Miller KL; Lord B; McAllister HM; Tognarelli DJ; Wu J; Abad MC; Schubert C; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 Feb; 17(4):1047-51. PubMed ID: 17127059
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors.
Keith JM; Gomez LA; Wolin RL; Barbier AJ; Wilson SJ; Boggs JD; Mazur C; Fraser IC; Lord B; Aluisio L; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 May; 17(9):2603-7. PubMed ID: 17317177
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR of novel histamine H3 receptor antagonists.
Jesudason CD; Beavers LS; Cramer JW; Dill J; Finley DR; Lindsley CW; Stevens FC; Gadski RA; Oldham SW; Pickard RT; Siedem CS; Sindelar DK; Singh A; Watson BM; Hipskind PA
Bioorg Med Chem Lett; 2006 Jul; 16(13):3415-8. PubMed ID: 16677814
[TBL] [Abstract][Full Text] [Related]
7. 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.
Zaragoza F; Stephensen H; Peschke B; Rimvall K
J Med Chem; 2005 Jan; 48(1):306-11. PubMed ID: 15634025
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists.
Ali SM; Tedford CE; Gregory R; Handley MK; Yates SL; Hirth WW; Phillips JG
J Med Chem; 1999 Mar; 42(5):903-9. PubMed ID: 10072687
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
[TBL] [Abstract][Full Text] [Related]
10. 1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.
Zaragoza F; Stephensen H; Knudsen SM; Pridal L; Wulff BS; Rimvall K
J Med Chem; 2004 May; 47(11):2833-8. PubMed ID: 15139761
[TBL] [Abstract][Full Text] [Related]
11. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
12. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
Vaccaro WD; Sher R; Berlin M; Shih NY; Aslanian R; Schwerdt JH; McCormick KD; Piwinski JJ; West RE; Anthes JC; Williams SM; Wu RL; She HS; Rivelli MA; Mutter JC; Corboz MR; Hey JA; Favreau L
Bioorg Med Chem Lett; 2006 Jan; 16(2):395-9. PubMed ID: 16246552
[TBL] [Abstract][Full Text] [Related]
13. Theophylline derivatives as potential histamine H3-receptor antagonists.
Kieć-Kononowicz K; Cegła MT
Pharmazie; 1998 Aug; 53(8):518-21. PubMed ID: 9741061
[TBL] [Abstract][Full Text] [Related]
14. 4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.
Dvorak CA; Apodaca R; Barbier AJ; Berridge CW; Wilson SJ; Boggs JD; Xiao W; Lovenberg TW; Carruthers NI
J Med Chem; 2005 Mar; 48(6):2229-38. PubMed ID: 15771465
[TBL] [Abstract][Full Text] [Related]
15. Validation of a histamine H3 receptor model through structure-activity relationships for classical H3 antagonists.
Lorenzi S; Mor M; Bordi F; Rivara S; Rivara M; Morini G; Bertoni S; Ballabeni V; Barocelli E; Plazzi PV
Bioorg Med Chem; 2005 Oct; 13(19):5647-57. PubMed ID: 16085419
[TBL] [Abstract][Full Text] [Related]
16. Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists.
Walczyński K; Zuiderveld OP; Timmerman H
Eur J Med Chem; 2005 Jan; 40(1):15-23. PubMed ID: 15642406
[TBL] [Abstract][Full Text] [Related]
17. A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines.
Apodaca R; Dvorak CA; Xiao W; Barbier AJ; Boggs JD; Wilson SJ; Lovenberg TW; Carruthers NI
J Med Chem; 2003 Aug; 46(18):3938-44. PubMed ID: 12930154
[TBL] [Abstract][Full Text] [Related]
18. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
Berlin M; Ting PC; Vaccaro WD; Aslanian R; McCormick KD; Lee JF; Albanese MM; Mutahi MW; Piwinski JJ; Shih NY; Duguma L; Solomon DM; Zhou W; Sher R; Favreau L; Bryant M; Korfmacher WA; Nardo C; West RE; Anthes JC; Williams SM; Wu RL; Susan She H; Rivelli MA; Corboz MR; Hey JA
Bioorg Med Chem Lett; 2006 Feb; 16(4):989-94. PubMed ID: 16297617
[TBL] [Abstract][Full Text] [Related]
19. Acidic elements in histamine H(3) receptor antagonists.
Sander K; von Coburg Y; Camelin JC; Ligneau X; Rau O; Schubert-Zsilavecz M; Schwartz JC; Stark H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1581-4. PubMed ID: 20138762
[TBL] [Abstract][Full Text] [Related]
20. Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.
Pelloux-Léon N; Fkyerat A; Piripitsi A; Tertiuk W; Schunack W; Stark H; Garbarg M; Ligneau X; Arrang JM; Schwartz JC; Ganellin CR
J Med Chem; 2004 Jun; 47(12):3264-74. PubMed ID: 15163206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
